MLSS icon

Milestone Scientific

0.8800 USD
-0.0101
1.13%
At close Jun 13, 4:00 PM EDT
After hours
0.9030
+0.0230
2.61%
1 day
-1.13%
5 days
-1.18%
1 month
-3.30%
3 months
-4.34%
6 months
8.64%
Year to date
-6.39%
1 year
24.93%
5 years
-64.80%
10 years
-76.15%
 

About: Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.

Employees: 17

0
Funds holding %
of 7,296 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0.33% less ownership

Funds ownership: 5.7% [Q4 2024] → 5.37% (-0.33%) [Q1 2025]

8% less capital invested

Capital invested by funds: $4.26M [Q4 2024] → $3.9M (-$360K) [Q1 2025]

17% less funds holding

Funds holding: 35 [Q4 2024] → 29 (-6) [Q1 2025]

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

Research analyst outlook

We haven’t received any recent analyst ratings for MLSS.

Financial journalist opinion

Neutral
GlobeNewsWire
3 weeks ago
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
Brings Proven Commercial Leadership, Reimbursement Expertise, and Global Market Insight to Support Next Phase of Growth Across Medical and Dental Segments Brings Proven Commercial Leadership, Reimbursement Expertise, and Global Market Insight to Support Next Phase of Growth Across Medical and Dental Segments
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
Neutral
GlobeNewsWire
4 weeks ago
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025
ROSELAND, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and reported financial results for the first quarter ended March 31, 2025.
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025
Neutral
GlobeNewsWire
2 months ago
Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey
Dr. Roman Kosiborod, DO to Utilize CompuFlo® for Enhanced Precision in Pain Management Procedures Dr. Roman Kosiborod, DO to Utilize CompuFlo® for Enhanced Precision in Pain Management Procedures
Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey
Neutral
GlobeNewsWire
4 months ago
Milestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLC
Dr. Ilana Etelzon Integrates CompuFlo® Epidural System into Practice Following Positive Clinical Experience Dr. Ilana Etelzon Integrates CompuFlo® Epidural System into Practice Following Positive Clinical Experience
Milestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLC
Neutral
GlobeNewsWire
4 months ago
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon
Reports Expanding Adoption of CompuFlo® Epidural System Following Previously Announced Medicare Price Assignment Reports Expanding Adoption of CompuFlo® Epidural System Following Previously Announced Medicare Price Assignment
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon
Neutral
GlobeNewsWire
6 months ago
Milestone Scientific to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference on December 11th, 2024
ROSELAND, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its CEO Arjan Haverhals and Chairman Neal Goldman will be presenting at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024 at the New York Athletic Club in New York City.
Milestone Scientific to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference on December 11th, 2024
Neutral
GlobeNewsWire
6 months ago
Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System
Contract Unlocks Significant Market Opportunities Across Federal Healthcare Systems Contract Unlocks Significant Market Opportunities Across Federal Healthcare Systems
Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System
Neutral
Seeking Alpha
6 months ago
Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Transcript
Milestone Scientific Inc. (NYSE:MLSS ) Q3 2024 Earnings Call Transcript November 15, 2024 8:30 AM ET Company Participants David Waldman - Crescendo Communications, Investor Relations Arjan Haverhals - Chief Executive Officer and President Keisha Harcum - Vice President, Finance Conference Call Participants Nick Sherwood - Maxim Group. Bruce Jackson - Benchmark Company Operator Good morning, everyone.
Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
6 months ago
Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
Reports 57% increase in international dental sales for the third quarter of 2024 Advances commercial rollout of CompuFlo® Epidural System across additional pain management clinics following Medicare price assignment in multiple U.S. states ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported financial results for the third quarter ended September 30, 2024.
Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
Neutral
GlobeNewsWire
6 months ago
Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO
ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support through the leadership transition.
Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO
Charts implemented using Lightweight Charts™